Changes in the profiles of pro-inflammatory and anti-inflammatory cytokines, such as IL-1β TNF-α and TGf-β, have also been observed in NAFLD [47,48,49]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.